Estradiol/norethisterone acetate
Estradiol/norethisterone acetate (E2/NETA), sold under brand names including Activella, Amabelz, Estracomb, Kliofem, and Novofem, is a combination of estradiol (E2) and norethisterone acetate (NETA) which is used in the treatment of vasomotor symptoms, vulvar and vaginal atrophy, and osteoporosis[1] associated with menopause.[2] Activella specifically is marketed by Novo Nordisk and is supplied as film-coated tablets containing 1 mg estradiol and 0.5 mg norethisterone acetate. CombiPatch is a combination of estradiol and NETA provided as a transdermal patch.[2]
Combination of | |
---|---|
Estradiol | Estrogen |
Norethisterone acetate | Progestogen |
Clinical data | |
Trade names | Activella, Amabelz, CombiPatch Estracomb, Kliofem, Novofem |
AHFS/Drugs.com | Monograph |
MedlinePlus | a601041 |
Pregnancy category |
|
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
![]() ![]() |
See also
References
- Morabito, Nunziata; Crisafulli, Alessandra; Vergara, Caterina; Gaudio, Agostino; Lasco, Antonino; Frisina, Nicola; D'Anna, Rosario; Corrado, Francesco; Pizzoleo, Maria Antonia; Cincotta, Maria; Altavilla, Domenica; Ientile, Riccardo; Squadrito, Francesco (1 October 2002). "Effects of Genistein and Hormone-Replacement Therapy on Bone Loss in Early Postmenopausal Women: A Randomized Double-Blind Placebo-Controlled Study". Journal of Bone and Mineral Research. 17 (10): 1904–1912. doi:10.1359/jbmr.2002.17.10.1904.
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020870s023lbl.pdf
Progestogens (and progestins) |
| ||||
---|---|---|---|---|---|
Antiprogestogens |
| ||||
|
Estrogen receptor modulators | |||||||
---|---|---|---|---|---|---|---|
ER |
| ||||||
GPER |
| ||||||
|
Progesterone receptor modulators | |||||||
---|---|---|---|---|---|---|---|
PR |
| ||||||
mPR (PAQR) |
| ||||||
|
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.